Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022

SELL
$8.55 - $111.89 $480,886 - $6.29 Million
-56,244 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$76.53 - $110.43 $641,397 - $925,513
8,381 Added 17.51%
56,244 $5.96 Million
Q2 2021

Jul 28, 2021

BUY
$85.37 - $114.1 $319,966 - $427,646
3,748 Added 8.5%
47,863 $4.09 Million
Q1 2021

May 19, 2021

BUY
$109.73 - $153.66 $2.36 Million - $3.31 Million
21,529 Added 95.32%
44,115 $5.06 Million
Q4 2020

Mar 08, 2021

BUY
$79.58 - $152.45 $1.09 Million - $2.08 Million
13,652 Added 152.81%
22,586 $3.16 Million
Q4 2019

Feb 13, 2020

BUY
$66.49 - $137.73 $594,021 - $1.23 Million
8,934 New
8,934 $852,000

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $89.8M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Teachers Retirement System Of The State Of Kentucky Portfolio

Follow Teachers Retirement System Of The State Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teachers Retirement System Of The State Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Teachers Retirement System Of The State Of Kentucky with notifications on news.